GR3033600T3 - Transformed endothelial cells. - Google Patents

Transformed endothelial cells.

Info

Publication number
GR3033600T3
GR3033600T3 GR20000401135T GR20000401135T GR3033600T3 GR 3033600 T3 GR3033600 T3 GR 3033600T3 GR 20000401135 T GR20000401135 T GR 20000401135T GR 20000401135 T GR20000401135 T GR 20000401135T GR 3033600 T3 GR3033600 T3 GR 3033600T3
Authority
GR
Greece
Prior art keywords
cells
kappa
endothelial cells
activity
endothelial
Prior art date
Application number
GR20000401135T
Other languages
English (en)
Inventor
Fritz H Bach
Martin Rainer De
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of GR3033600T3 publication Critical patent/GR3033600T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR20000401135T 1992-11-02 2000-06-30 Transformed endothelial cells. GR3033600T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929222931A GB9222931D0 (en) 1992-11-02 1992-11-02 Organic compounds
PCT/EP1993/003015 WO1994010305A1 (en) 1992-11-02 1993-10-29 Transformed endothelial cells

Publications (1)

Publication Number Publication Date
GR3033600T3 true GR3033600T3 (en) 2000-09-29

Family

ID=10724398

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401135T GR3033600T3 (en) 1992-11-02 2000-06-30 Transformed endothelial cells.

Country Status (16)

Country Link
EP (1) EP0669977B1 (el)
JP (1) JPH08502653A (el)
KR (1) KR950704477A (el)
AT (1) ATE192492T1 (el)
AU (1) AU680636B2 (el)
CA (1) CA2143489A1 (el)
DK (1) DK0669977T3 (el)
ES (1) ES2146235T3 (el)
FI (1) FI952088A0 (el)
GB (1) GB9222931D0 (el)
GR (1) GR3033600T3 (el)
NO (1) NO951628L (el)
NZ (1) NZ257539A (el)
PT (1) PT669977E (el)
RU (1) RU2164415C2 (el)
WO (1) WO1994010305A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
EP0815252A1 (en) * 1995-03-24 1998-01-07 Novartis AG Gene therapy for transplantation and inflammatory or thrombotic conditions
US5981486A (en) * 1995-04-13 1999-11-09 Chugai Seiyaku Kabushiki Kaisha Peptide suppressing IκBα phosphorylation
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
EP0779361A3 (en) 1995-12-15 1999-11-10 F. Hoffmann-La Roche Ag Truncated form of inhibitory kappa B protein (1kB), recombinant production and uses thereof
CA2245503A1 (en) * 1996-02-14 1997-08-21 Novartis Ag Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
AU2001231009A1 (en) 2000-01-21 2001-07-31 Beth Israel Deaconess Medical Center Use of pro-apoptotic factors in treatment of atherosclerosis
WO2006040615A2 (en) * 2003-06-11 2006-04-20 Jan Remmereit Differenciation of stem cells for therapeutic use
TW201120210A (en) 2009-11-05 2011-06-16 Hoffmann La Roche Glycosylated repeat-motif-molecule conjugates
CA2830013C (en) 2011-04-01 2020-01-07 Chugai Seiyaku Kabushiki Kaisha Recombinant polypeptide production method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008147A1 (en) * 1988-03-01 1989-09-08 Whitehead Institute For Biomedical Research ACTIVITION OF NF-kB PRECURSOR
EP0556345B2 (en) * 1990-10-31 2005-10-12 Cell Genesys, Inc. Retroviral vectors useful for gene therapy

Also Published As

Publication number Publication date
ES2146235T3 (es) 2000-08-01
FI952088L (fi) 1995-05-02
KR950704477A (ko) 1995-11-20
FI952088A7 (fi) 1995-05-02
NO951628L (no) 1995-07-03
EP0669977B1 (en) 2000-05-03
JPH08502653A (ja) 1996-03-26
ATE192492T1 (de) 2000-05-15
NO951628D0 (no) 1995-04-28
FI952088A0 (fi) 1995-05-02
AU680636B2 (en) 1997-08-07
GB9222931D0 (en) 1992-12-16
NZ257539A (en) 1996-08-27
EP0669977A1 (en) 1995-09-06
WO1994010305A1 (en) 1994-05-11
RU2164415C2 (ru) 2001-03-27
DK0669977T3 (da) 2000-08-07
PT669977E (pt) 2000-08-31
AU5440494A (en) 1994-05-24
CA2143489A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
GB2091271B (en) Recombinant dna
CA2063810A1 (en) Production of vascular endothelial cell growth factor
BG105567A (en) Expression system for factor viii
HUT50491A (en) Zea mays and transgen zea mays regenerated from protoplasts or celles originated from protoplasts
DE69420726D1 (de) Embryonische stammzelle zur herstellung von chimäre und transgen-ongulaten
NZ221119A (en) Proteins with factor viii activity produced by microorganisms produced by genetic engineering
IL135578A0 (en) Compositions and methods for treating lysosomal storage disease
GB9311147D0 (en) Regulation of plant growth
DK0669977T3 (da) Transformerede endothelceller
CA2095861A1 (en) Structural proteins from artificial genes
EP0349342A3 (en) Polypeptides with cell-spreading activity
DE69535604D1 (en) Transgenes fibrinogen
IL115728A0 (en) Biomaterial containing epithelial cells and use thereof as a transplant
ZA843015B (en) Novel strain of trichoderma harzianum,method of isolating said strain,method of cultivating said strain,novel peptides or compounds produced from said strain,and application of said strain and of said novel peptides or of the product obtained by the cultivation method as a biologically active means in the form of a plant-disease control product
PT1621633E (pt) Glicoproteínas produzidas em plantas com supressão da expressão de beta 1,2-xilosiltransferase
DE60017139D1 (de) Pflanzenwurzelspezifischer promotor, rekombinante vektoren und wirtszellen die diesen enthalten und korrespondierende transgene pflanzen
RU95110697A (ru) ЭНДОТЕЛИАЛЬНАЯ КЛЕТКА, В КОТОРОЙ ЭКСПРЕССИРУЕТСЯ БЕЛОК, ОБЛАДАЮЩИЙ IκB, АКТИВНОСТЬЮ (ВАРИАНТЫ), ТКАНЬ И ДОНОРНЫЙ ОРГАН, СОДЕРЖАЩИЙ ТАКИЕ КЛЕТКИ, ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК, КОДИРУЮЩАЯ ДАННЫЙ БЕЛОК (ВАРИАНТЫ), РЕКОМБИНАНТНАЯ КОНСТРУКЦИЯ ДНК, СПОСОБЫ ПОЛУЧЕНИЯ ТАКИХ ЭНДОТЕЛИАЛЬНЫХ КЛЕТОК, БЕЛОК, ОБЛАДАЮЩИЙ IκB- АКТИВНОСТЬЮ
EP0429538A4 (en) Plant elongation factor, promoters, coding sequences and uses
DE69331434D1 (de) Mutanter AOX2 Promotor, diesen enthaltender Vektor, transformierte Zellen und Herstellung von heterologen Proteinen
NZ209467A (en) Herbicidal composition derived from phomopsis cirsii and septoria cirsii
DE59914540D1 (de) Transgene pflanzen und pflanzenzellen mit verminderter expression von invertaseinhibitoren
Gregov et al. Dynamics of height control in spray chrysanthemums affected by growth retardants
Carella et al. Eradication of the Philadelphia chromosome-positive clone and persistent restoration of normal polyclonal haemopoiesis in a chronic myelogenous leukemia patient after autologous transplant with peripheral blood Philadelphia-negative haemopoietic cells
ATE401001T1 (de) Pflanzen zur kontrolle von schäden verursacht durch fressende insekten
WO1998035027A3 (en) Human nerve growth factor exon 1 and exon 3 promoters

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees